Odyssey Health, Inc. (ODYY) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US67612C1027
Odyssey Health, Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -1.02 m USD | -912,994.00 USD |
| EBIT | -1.49 m USD | -4.15 m USD |
| Net income | -1.74 m USD | -5.73 m USD |
| Diluted EPS – continuing operations | -0.02 USD | -0.05 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Odyssey Health, Inc.
Odyssey Health, Inc., a medical company, focuses on the development and acquisition of medical products and health related technologies. The company develops CardioMap, a heart monitoring and screening device; and Save A Life choking rescue devices. Its product candidates include ONP-002 for the treatment of mild brain trauma or concussion. The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was incorporated in 2014 and is based in Las Vegas, Nevada.
More stocks
- Sky Century Investment, Inc. (SKYI)
- Dream Homes & Development Corp. (DREM)
- Yubo International Biotech Ltd (YBGJ)
- Naploy Corp. (NPLY)
- iPower Inc. (IPW)
- Pony Group Inc. (PNYG)
- Authentic Holdings, Inc. (AHRO)
- Hi-Great Group Holding Co (HIGR)
- GENERATION INCOME PROPERTIES, INC. (GIPR)
- B-Scada, Inc. (SCDA)
- Rapid Line Inc. (RPDL)
- TANCHENG GROUP CO., LTD. (QSJC)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.